Lyell Immunopharma, Inc.
LYEL· Nasdaq
Lyell Immunopharma, Inc.
- Last sale
- Oct 2, 2026 · -1.17%
- Market cap
- $227.41M
- 24.51M shares
- Filings
- 353
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $36,000 | reported | |
| FY 2024 | 2024-12-31 | $61,000 | reported | |
| FY 2023 | 2023-12-31 | $130,000 | reported | |
| FY 2022 | 2022-12-31 | $84,683,000 | reported | |
| FY 2021 | 2021-12-31 | $10,650,000 | reported | |
| FY 2020 | 2020-12-31 | $7,756,000 | reported | |
| FY 2019 | 2019-12-31 | $657,000 | reported |
Lyell Immunopharma, Inc. · CIK 1806952 · Engraved from SEC EDGAR
